dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate

C56H64BBrF4K2N14O7 — CID 159215295

About dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate

dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate (PubChem CID 159215295) has the molecular formula C56H64BBrF4K2N14O7 and a molecular weight of 1290.12 g/mol. Its IUPAC name is dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate.

Molecular Properties

• Compound Name: dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate
• PubChem CID: 159215295
• Molecular Formula: C56H64BBrF4K2N14O7
• Molecular Weight: 1290.12 g/mol
• Exact Mass: 1288.36
• IUPAC Name: dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate
• SMILES: C.CC1C(=O)N(C)Cc2c(Br)nc(C3CC3)n21.Cc1cn(-c2nc3cccc(-c4nc(C5CC5)n5c4CN(C)C(=O)C5C)c3cc2C(F)F)nn1.Cc1cn(-c2nc3cccc(B4OC(C)(C)C(C)(C)O4)c3cc2C(F)F)nn1.O=CO[O-].[H-].[K+].[K+]
• InChI: InChI=1S/C24H23F2N7O.C19H21BF2N4O2.C11H14BrN3O.CH2O3.CH4.2K.H/c1-12-10-32(30-29-12)23-17(21(25)26)9-16-15(5-4-6-18(16)27-23)20-19-11-31(3)24(34)13(2)33(19)22(28-20)14-7-8-14;1-11-10-26(25-24-11)17-13(16(21)22)9-12-14(7-6-8-15(12)23-17)20-27-18(2,3)19(4,5)28-20;1-6-11(16)14(2)5-8-9(12)13-10(15(6)8)7-3-4-7;2-1-4-3;;;;/h4-6,9-10,13-14,21H,7-8,11H2,1-3H3;6-10,16H,1-5H3;6-7H,3-5H2,1-2H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1
• InChIKey: HDPZHFPFCMTWDM-UHFFFAOYSA-M
• XLogP: 2.94
• TPSA: 231.28 Ų
• H-Bond Acceptors: 19
• Rotatable Bonds: 9
• Heavy Atoms: 85
• Complexity: —

Lipinski Rule of Five

2 violations

Rule	Value
MW ≤ 500	1290.12
LogP ≤ 5	2.94
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	19

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?

The IUPAC name of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate (CID 159215295) is dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate.

What is the SMILES notation for dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?

The canonical SMILES for dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate is C.CC1C(=O)N(C)Cc2c(Br)nc(C3CC3)n21.Cc1cn(-c2nc3cccc(-c4nc(C5CC5)n5c4CN(C)C(=O)C5C)c3cc2C(F)F)nn1.Cc1cn(-c2nc3cccc(B4OC(C)(C)C(C)(C)O4)c3cc2C(F)F)nn1.O=CO[O-].[H-].[K+].[K+].

What is the InChIKey of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?

The InChIKey is HDPZHFPFCMTWDM-UHFFFAOYSA-M. The full InChI is InChI=1S/C24H23F2N7O.C19H21BF2N4O2.C11H14BrN3O.CH2O3.CH4.2K.H/c1-12-10-32(30-29-12)23-17(21(25)26)9-16-15(5-4-6-18(16)27-23)20-19-11-31(3)24(34)13(2)33(19)22(28-20)14-7-8-14;1-11-10-26(25-24-11)17-13(16(21)22)9-12-14(7-6-8-15(12)23-17)20-27-18(2,3)19(4,5)28-20;1-6-11(16)14(2)5-8-9(12)13-10(15(6)8)7-3-4-7;2-1-4-3;;;;/h4-6,9-10,13-14,21H,7-8,11H2,1-3H3;6-10,16H,1-5H3;6-7H,3-5H2,1-2H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1.

What are the key properties of dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate?

dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate has a molecular weight of 1290.12 g/mol, XLogP of 2.94, 9 rotatable bonds, 0 hydrogen bond donors, and 19 hydrogen bond acceptors.

Where does this data come from?

All data for dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(difluoromethyl)-2-(4-methyltriazol-1-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(difluoromethyl)-2-(4-methyltriazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline;hydride;methane;oxido formate is sourced from PubChem (CID 159215295), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).